These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18869371)

  • 21. A multidisciplinary review of nutrition considerations in the pediatric oncology population: a perspective from children's oncology group.
    Ladas EJ; Sacks N; Meacham L; Henry D; Enriquez L; Lowry G; Hawkes R; Dadd G; Rogers P
    Nutr Clin Pract; 2005 Aug; 20(4):377-93. PubMed ID: 16207678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anesthetic considerations for the pediatric oncology patient--part 1: a review of antitumor therapy.
    Latham GJ; Greenberg RS
    Paediatr Anaesth; 2010 Apr; 20(4):295-304. PubMed ID: 20470332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oncology pharmacy specialists in oncology].
    Ikesue H; Oishi R
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):578-82. PubMed ID: 18408426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardio-oncology organization patterns in Italy: one size does not fit all.
    Canale ML; Lestuzzi C; Bisceglia I; Vallerio P; Parrini I;
    J Cardiovasc Med (Hagerstown); 2018 May; 19(5):229-233. PubMed ID: 29528869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Companion diagnostics in oncology - current status and future aspects.
    Jørgensen JT
    Oncology; 2013; 85(1):59-68. PubMed ID: 23860090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of Mayo Clinic's early screen for discharge planning tool for predicting patient length of stay, discharge destination, and readmission risk in an inpatient oncology cohort.
    Socwell CP; Bucci L; Patchell S; Kotowicz E; Edbrooke L; Pope R
    Support Care Cancer; 2018 Nov; 26(11):3843-3849. PubMed ID: 29777381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential Drug-drug Interactions at a Referral Pediatric Oncology Ward in Iran: A Cross-sectional Study.
    Tavousi F; Sadeghi A; Darakhshandeh A; Moghaddas A
    J Pediatr Hematol Oncol; 2019 Apr; 41(3):e146-e151. PubMed ID: 30531601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New anticancer agents: role of clinical pharmacy services.
    Leveque D; Delpeuch A; Gourieux B
    Anticancer Res; 2014 Apr; 34(4):1573-8. PubMed ID: 24692684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Decree by which the Secretariat of Health and Welfare will organize the National Cancer Registry].
    Salud Publica Mex; 1983; 25(1):105-6. PubMed ID: 6879313
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of adherence with oral anticancer agents in oncology clinical trials: A systematic review.
    Bergsbaken JJ; Eickhoff JC; Buss BA; Mably MS; Kolesar JM
    J Oncol Pharm Pract; 2016 Feb; 22(1):105-13. PubMed ID: 25577495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).
    Krishna R; Mayer LD
    Anticancer Res; 1999; 19(4B):2885-91. PubMed ID: 10652569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The treatment of cancer patients near their residence in the territorial structure "Casa della salute": preliminary results in the province of Piacenza (Italy).].
    Mordenti P; Proietto M; Citterio C; Vecchia S; Cavanna L
    Recenti Prog Med; 2018 Jun; 109(6):337-341. PubMed ID: 29968863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospice and hospital oncology unit nurses: a comparative survey of knowledge and attitudes about cancer pain.
    Hollen CJ; Hollen CW; Stolte K
    Oncol Nurs Forum; 2000; 27(10):1593-9. PubMed ID: 11103378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The integration of palliative care and oncology: the evidence.
    Von Roenn JH; Temel J
    Oncology (Williston Park); 2011 Nov; 25(13):1258-60, 1262, 1264-5. PubMed ID: 22272492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of oncology clinical trials: a review.
    Ananthakrishnan R; Menon S
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):144-53. PubMed ID: 23623356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease.
    Dome B; Dobos J; Tovari J; Paku S; Kovacs G; Ostoros G; Timar J
    Cytometry A; 2008 Mar; 73(3):186-93. PubMed ID: 18000872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosimilars: Considerations for Oncology Nurses
.
    Vizgirda V; Jacobs I
    Clin J Oncol Nurs; 2017 Apr; 21(2):E54-E60. PubMed ID: 28315542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral delivery of anticancer drugs I: general considerations.
    Mazzaferro S; Bouchemal K; Ponchel G
    Drug Discov Today; 2013 Jan; 18(1-2):25-34. PubMed ID: 22951365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The medical oncology clinic].
    Velu T; Brandenburger A; Bruyns C; Gangji D; Tenenbaum L
    Rev Med Brux; 2002; 23 Suppl 2():131-6. PubMed ID: 12584929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Building a funded research program in cancer health disparities: considerations for young investigators.
    Ochs-Balcom HM; Phillips LS; Nichols HB; Martinez E; Thompson B; Ojeifo J; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):882-5. PubMed ID: 25934837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.